FLKS - Flex Pharma, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue838.1421,274.4991,010.663-
Cost of Revenue430.75506.53662.747-
Gross Profit407.392767.969347.916-
Operating Expenses
Research Development10,940.29416,989.91120,378.16112,749.379
Selling General and Administrative10,175.32118,503.68419,570.98716,464.279
Non Recurring----
Others----
Total Operating Expenses21,546.36536,000.12540,611.89529,213.658
Operating Income or Loss-20,708.223-34,725.626-39,601.232-29,213.658
Income from Continuing Operations
Total Other Income/Expenses Net-1,213.994291.964108.10972.028
Earnings Before Interest and Taxes-20,708.223-34,725.626-39,601.232-29,213.658
Interest Expense----
Income Before Tax-21,922.217-34,433.662-39,493.123-29,141.63
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-21,922.217-34,433.662-39,493.123-29,141.63
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-21,922.217-34,433.662-39,493.123-29,141.63
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-21,922.217-34,433.662-39,493.123-29,141.63